Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
About This Trial
Smoking remains the single most preventable cause of morbidity and mortality in the United States, accounting for approximately half a million deaths every year. The current study will investigate the efficacy and mechanisms of change of a novel smoking cessation intervention. The current study will thus provide essential information regarding a treatment that has the potential to enhance the efficacy of existing smoking cessation interventions, thereby having a beneficial impact on the public health of the United States.
Who May Be Eligible (Plain English)
Original Eligibility Criteria
View original clinical language
Treatments Being Tested
cognitive-behavioral withdrawal regulation strategies
Participants will generate and refine individualized withdrawal regulation strategies with the aid of a therapist
relaxation strategies
Participants will generate and refine relaxation techniques with the aid of a therapist
early withdrawal exposure
Exposure to the first 4 hours of abstinence across 4 separate sessions